FdaApplication
ANDA 213713
Identifiers
- fda_app_no: ANDA213713
Properties
| Property | Value |
|---|---|
| applicant_name | SANDOZ INC |
| application_type | ANDA |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| RIFAXIMIN | RIFAXIMIN | 550MG | TABLET;ORAL |
1 product
FdaApplication
| Property | Value |
|---|---|
| applicant_name | SANDOZ INC |
| application_type | ANDA |
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| RIFAXIMIN | RIFAXIMIN | 550MG | TABLET;ORAL |
1 product